BY SEAN WHOOLEY
Congestive heart failure treatment developer Alleviant Medical filed an SEC Form D to confirm the sale of $6.5 million in an equity offering.
The Austin, Texas-based company reached its total offering amount of $6.5 million after making the first sale in the new notice on May 1. It had no intention of letting the offering last longer than one year and did not make it in connection with a business transaction.
With no minimum investment required for the equity offering, a total of 18 investors contributed to the sale, which did not have an issuer size disclosed.